Concerted Activation of ETS Protein ER81 by p160 Coactivators, the Acetyltransferase p300 and the Receptor Tyrosine Kinase HER2/Neu*

Activator of thyroid and retinoic acid receptor (ACTR) is overexpressed in ∼60% of primary human breast tumors and belongs to the p160 steroid receptor coactivator family. In this study, we identified a novel interaction partner of ACTR, the ETS transcription factor ER81 that is also heavily implicated in mammary tumor formation. ACTR and related p160 family members (steroid receptor coactivator-1 and glucocorticoid receptor-interacting protein-1 (GRIP-1)) augment ER81-mediated transcription. Although ACTR and GRIP-1 can acetylate ER81, this posttranslational modification of ER81 is not required for its stimulation by ACTR or GRIP-1. In addition, ACTR collaborates with the p300 coactivator, a joint interaction partner of ACTR and ER81, to stimulate ER81 function and the ability of p300 to acetylate ER81 is indispensable for this collaboration. Furthermore, the receptor tyrosine kinase HER2/Neu, an oncoprotein particularly found overexpressed in breast tumors, cooperates with both ACTR and p300 to stimulate ER81-mediated transcription. Thus, oncogenic HER2/Neu and ACTR may synergize to orchestrate mammary tumorigenesis through the dysregulation of the transcription factor ER81 and its target genes.

[1]  A. Nordheim,et al.  Signal integration at the c-fos promoter. , 1995, Carcinogenesis.

[2]  Andrew J. Bannister,et al.  E1A directly binds and regulates the P/CAF acetyltransferase , 1998, The EMBO journal.

[3]  R. Janknecht,et al.  Phosphorylation of ETS Transcription Factor ER81 in a Complex with Its Coactivators CREB-Binding Protein and p300 , 2000, Molecular and Cellular Biology.

[4]  Qin Chen,et al.  CREB-binding Protein/p300 Co-activation of Crystallin Gene Expression* , 2002, The Journal of Biological Chemistry.

[5]  Y. Yarden,et al.  A single autophosphorylation site confers oncogenicity to the Neu/ErbB‐2 receptor and enables coupling to the MAP kinase pathway. , 1994, The EMBO journal.

[6]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[7]  Yusuke Nakamura,et al.  Amplification and over‐expression of the AIB1 nuclear receptor co‐activator gene in primary gastric cancers , 2000, International journal of cancer.

[8]  R. Janknecht,et al.  Regulation of the ETS Transcription Factor ER81 by the 90-kDa Ribosomal S6 Kinase 1 and Protein Kinase A* , 2002, The Journal of Biological Chemistry.

[9]  Hui Li,et al.  RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Shih-Ming Huang,et al.  Synergistic, p160 Coactivator-dependent Enhancement of Estrogen Receptor Function by CARM1 and p300* , 2000, The Journal of Biological Chemistry.

[11]  R. Janknecht.  Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1) , 2003, Oncogene.

[12]  J. Horton.  Trastuzumab use in breast cancer: clinical issues. , 2002, Cancer control : journal of the Moffitt Cancer Center.

[13]  C. Lyttle,et al.  A Transcriptional Coactivator, Steroid Receptor Coactivator-3, Selectively Augments Steroid Receptor Transcriptional Activity* , 1998, The Journal of Biological Chemistry.

[14]  Han-Jong Kim,et al.  Steroid Receptor Coactivator-1 Interacts with Serum Response Factor and Coactivates Serum Response Element-mediated Transactivations* , 1998, The Journal of Biological Chemistry.

[15]  A. Mariani,et al.  HER2/Neu- and TAK1-mediated Up-regulation of the Transforming Growth Factor β Inhibitor Smad7 via the ETS Protein ER81* , 2003, Journal of Biological Chemistry.

[16]  R. Janknecht,et al.  HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1 , 2001, Oncogene.

[17]  Shen-Liang Chen,et al.  The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. , 2000, Genes & development.

[18]  Hueng-Sik Choi,et al.  Steroid Receptor Coactivator-1 Interacts with the p50 Subunit and Coactivates Nuclear Factor κB-mediated Transactivations* , 1998, The Journal of Biological Chemistry.

[19]  A. Sharrocks.  The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.

[20]  R. Janknecht.  Cell Type-specific Inhibition of the ETS Transcription Factor ER81 by Mitogen-activated Protein Kinase-activated Protein Kinase 2* , 2001, The Journal of Biological Chemistry.

[21]  M. Southey,et al.  Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. , 2001, Cancer research.

[22]  B. Fingleton,et al.  The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors , 2001, Molecular and Cellular Biology.

[23]  B. O’Malley,et al.  Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Muller,et al.  The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis , 2001, Current Biology.

[25]  R. Janknecht,et al.  The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. , 2002, Histology and histopathology.

[26]  A. Nordheim,et al.  Gene regulation by Ets proteins. , 1993, Biochimica et biophysica acta.

[27]  C. Allis,et al.  Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.

[28]  M. Campiglio,et al.  Role of HER2 gene overexpression in breast carcinoma , 2000, Journal of cellular physiology.

[29]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[30]  Jianming Xu,et al.  Review of the in vivo functions of the p160 steroid receptor coactivator family. , 2003, Molecular endocrinology.

[31]  A. Nordheim,et al.  SAP1a is a nuclear target of signaling cascades involving ERKs. , 1995, Oncogene.

[32]  O. Hermanson,et al.  Regulation of somatic growth by the p160 coactivator p/CIP. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Hynes,et al.  The ErbB receptors and their role in cancer progression. , 2003, Experimental cell research.

[34]  Baljit Singh,et al.  Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue , 2001, Breast Cancer Research and Treatment.

[35]  Y. De Launoit,et al.  The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis. , 2000, Advances in experimental medicine and biology.

[36]  K. Chew,et al.  HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer , 1997, Oncogene.

[37]  L. Liao,et al.  Steroid Receptor Coactivator-3 Is Required for Inhibition of Neointima Formation by Estrogen , 2002, Circulation.

[38]  R. Janknecht,et al.  Upregulation of the matrix metalloproteinase‐1 gene by the Ewing's sarcoma associated EWS‐ER81 and EWS‐Fli‐1 oncoproteins, c‐Jun and p300 , 2003, FEBS letters.

[39]  D. Aswad,et al.  Regulation of transcription by a protein methyltransferase. , 1999, Science.

[40]  M. Stallcup,et al.  Synergistic Enhancement of Nuclear Receptor Function by p160 Coactivators and Two Coactivators with Protein Methyltransferase Activities* , 2001, The Journal of Biological Chemistry.

[41]  Christopher K. Glass,et al.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.

[42]  Hueng-Sik Choi,et al.  Steroid Receptor Coactivator-1 Coactivates Activating Protein-1-mediated Transactivations through Interaction with the c-Jun and c-Fos Subunits* , 1998, The Journal of Biological Chemistry.

[43]  W. Muller,et al.  PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. , 1993, Oncogene.

[44]  J. Wong,et al.  Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. , 2003, Molecular endocrinology.

[45]  B. Graves,et al.  Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.

[46]  B. O’Malley,et al.  Molecular Mechanisms and Cellular Biology of the Steroid Receptor Coactivator (SRC) Family in Steroid Receptor Function , 2002, Reviews in Endocrine and Metabolic Disorders.

[47]  P. Meltzer,et al.  In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  A. Wellstein,et al.  An Isoform of the Coactivator AIB1 That Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer* , 2001, The Journal of Biological Chemistry.

[49]  R. Janknecht.  Analysis of the ERK-stimulated ETS transcription factor ER81 , 1996, Molecular and cellular biology.

[50]  R. Sutherland,et al.  Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells , 1997, International journal of cancer.

[51]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[52]  J. Font de Mora,et al.  AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[53]  N. L. La Thangue,et al.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.

[54]  P. Meltzer,et al.  Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. , 1999, The American journal of pathology.

[55]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[56]  R. Janknecht,et al.  Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81 , 2002, Journal of cellular biochemistry.

[57]  M. Parker,et al.  Functional Interaction between the p160 Coactivator Proteins and the Transcriptional Enhancer Factor Family of Transcription Factors* , 2000, The Journal of Biological Chemistry.

[58]  R. Janknecht,et al.  Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf , 2004, Molecular and Cellular Biology.

[59]  C. Deng,et al.  The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[61]  R. Janknecht,et al.  Acetylation-Mediated Transcriptional Activation of the ETS Protein ER81 by p300, P/CAF, and HER2/Neu , 2003, Molecular and Cellular Biology.

[62]  N. Koibuchi,et al.  TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1* , 1997, The Journal of Biological Chemistry.

[63]  Luciano De Haro,et al.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter , 2002, Nucleic Acids Res..

[64]  C. Perry,et al.  Trastuzumab , 2002, Drugs.